Summary
Question of the study
Sleep loss and weight gain are assumed to be positively correlated, probably mediated by a decreased leptin secretion and/or an increased production of ghrelin. The present study measured evening and nocturnal serum leptin secretion in patients with chronic primary insomnia and healthy controls.
Methods
Eleven healthy controls (9 females, 2 males) and 11 patients suffering from primary insomnia (matched for age and gender) were studied in the sleep laboratory for 3 consecutive nights. Blood samples were taken in 2-h intervals from 1900 h to 0900 h prior to and during the third night and analyzed for serum leptin levels.
Results
Body mass index (BMI) was significantly higher in insomniac patients compared to healthy subjects. Polysomnography revealed expected differences between control subjects and insomniac patients. Leptin levels did not differ between patients and controls, also when controlling for the potential confounding influence of BMI by analysis of covariance. Leptin levels correlated positively with BMI values in both groups and negatively with the Pittsburgh sleep quality index (PSQI) scores only in the healthy sample.
Conclusion
Primary insomnia was not accompanied by an alteration in evening/nocturnal serum leptin levels. Further studies are warranted encompassing 24-h measurements of leptin in larger samples of patients with primary insomnia with varying degrees of BMI (carefully matched to healthy controls) and during different stages of the insomnia.
Zusammenfassung
Fragestellung
Es wird davon ausgegangen, dass Schlafverlust und Gewichtszunahme positiv korreliert sind, wobei dafür möglicherweise eine erniedrigte Leptin-Sekretion und/oder eine erhöhte Ghrelin-Produktion verantwortlich sind. Die vorliegende Studie untersuchte die abendliche und nächtliche Serum-Leptin-Sekretion bei Patienten mit chronischer primärer Insomnie und gesunden Kontrollpersonen.
Methoden
11 gesunde Kontrollpersonen (9 Frauen, 2 Männer) und 11 Patienten mit primärer Insomnie (alters-und geschlechtsvergleichbar) wurden im Schlaflabor für 3 konsekutive Nächte untersucht. Blutproben wurden in 2-stündlichen Abständen von 19.00 Uhr bis 9.00 Uhr morgens vor und während der dritten Nacht entnommen und hinsichtlich Serum-Leptin ausgewertet.
Ergebnisse
Der Body-Mass-Index (BMI) war signifikant bei Patienten mit primärer Insomnie im Vergleich zu gesunden Kontrollpersonen erhöht. Die Polysomnographie zeigte die erwarteten Unterschiede zwischen Kontrollpersonen und insomnischen Patienten. Die Leptin-Werte unterschieden sich nicht zwischen Patienten und Kontrollpersonen, auch wenn der potentielle konfundierende Einfluss des BMI durch Kovarianz-Analyse kontrolliert wurde. Die Leptin-Werte korrelierten positiv mit den BMI-Werten und negativ mit dem Pittsburgh Schlafqualitätsindex (PSQI) in beiden Gruppen.
Schlussfolgerung
Bei Patienten mit primärer Insomnie konnte keine Änderung der abendlichen/nächtlichen Serum-Leptin-Ausscheidung gezeigt werden. Weitere Studien werden benötigt, die mit Hilfe von 24-h-Messungen von Leptin in größeren Stichproben bei Patienten mit primärer Insomnie und unterschiedlichen Ausprägungen des BMI (gematcht mit gesunden Kontrollen und während verschiedenen Phasen einer Insomnie) durchgeführt werden.
Similar content being viewed by others
References
American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-IV). 4th edition. American Psychiatric Press, Washington DC, 1994.
Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB: A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26: 380–384, 2003.
Bonnet MH, Arand DL: 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 18: 581, 1995.
Buysse DJ, Reynolds CF, Monte TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193–213, 1989.
Fischer J, Mayer G, Peter HJ, Riemann D, Sitter H: Nichterholsamer Schlaf. Somnologie 5: 1–258, 2001.
Gomez-Merino D, Chennaoui M, Drogou C, Bonneau D, Guezennec CY: Decrease in serum leptin after prolonged physical activity in men. Med Sci Sports Exerc 10: 1594–1599, 2002.
Hardi L, Trayhurn P, Abramovich D, Fowler P: Circulating leptin in women: a longitudinal study in menstrual cycle and during pregnancy. Clin Endocrinol 47(1): 101–106, 1997.
Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Schahin SP, Wiest GH, Hahn EG, Lohmann T, Ficker JH: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22: 251–257, 2003.
Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D et al.: The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27: 661–666, 2004.
Mullington JM, Chan JL, Van Dongen HPA, Szuba MP, Samaras J, Price NJ, Meier-Ewert HK, Dinges DF, Mantzoros CS: Sleep loss reduces diumal rhythm amplitude of leptin in healthy men. J Neuroendocrinol 15: 851–854, 2003.
Nisson PM, Roost M, Engstrom G, Hedblad B, Berglund G: Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 27: 2464–2469, 2004.
Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ: Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 161: 2126–2129, 2004.
Öztürk L, Ünal M, Lülüfer T, Celikoglu F: The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 129: 538–540, 2003.
Patel SR, Redline S: Two epidemics: are we getting fatter as we sleep less? Sleep 27: 602–603, 2004.
Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK: Psychophysiological insomnia: the behavioral model and a neurocognitive perspective. J Sleep Res 6: 179–188, 1997.
Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Government Printing Office, Public Health Service. Washington, DC, 1968.
Riad-Gabriel MG, Jinagouda SD, Sharma A, Boyadjian R, Saad MF: Changes in plasma leptin during the menstrual cycle. Eur J Endocrinol 139(5): 528–531, 1998.
Riemann D, Klein T, Rodenbeck A, Feige B, Horny A, Hummel R, Weske G, Al-Shajlawi A, Voderholzer U: Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 113: 17–27, 2002.
Saaresranta T, Polo O: Does leptin link sleep loss and breathing disturbances with major public diseases? Ann Med 36: 172–183, 2004.
Schuld A, Blum WF, Uhr M, Haack M, Kraus T, Holsboer F, Pollmächer T: Reduced leptin levels in human narcolepsy. Neuroendocrinology 72: 195–198, 2000.
Simon C, Gronfier C, Schlienger JL, Brandenberger G: Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J Clin Endocrinol Metab 83: 1893–1899, 1998.
Spiegel K, Leproult R, L'Hermite-Balériaux M, Copinschi G, Penev PD, Van Cauter E: Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 89: 5762–5771, 2004.
Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435–1439, 1999.
Spiegel K, Tasali E, Penev P, Van Cauter E: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Med 141: 846–850, 2004.
Taheri S, Lin L, Austin D, Young T, Mignot E: Short sleep duration is associated with reduced leptin elevated ghrelin, and increased body mass index. Sleep 27 (Abstr. Suppl.): A146-A147, 2004.
Vgontzas AN, Bixler EO, Lin H-M, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP: Chronic insomnia is associated with nyctohemeral activation of the hypothalamicpituitary-adrenal axis: clinical Implications. J Clin Endocrinol Metab 86: 3787–3794, 2001.
Vgontzas AN, Zoumakis M, Bixler EO, Lin H-M, Prolo P, Vela-Bueno A, Kales A, Chrousos GP: Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 88: 2087–2095, 2003.
Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC: Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165: 25–30, 2005.
Wong M-A, Lieinio J, Yildiz BO, Mantzoros CS, Prolo P, Kling M, Gold PW: Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments. J Clin Endocrinol Metab 89: 258–265, 2004.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riemann, D., Burgos, I., Richter, L. et al. Nocturnal serum leptin values in chronic primary insomnia: A preliminary report. Somnologie 10, 192–199 (2006). https://doi.org/10.1111/j.1439-054X.2006.00102.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1439-054X.2006.00102.x